Alan S. Rabson
Alan S. Rabson (July 1, 1926 – July 4, 2018) was an American pathologist and cancer researcher. He served as the deputy director of the National Cancer Institute (NCI) and made significant contributions to the field of oncology.
Early Life and Education[edit | edit source]
Alan S. Rabson was born on July 1, 1926, in Brooklyn, New York City. He attended City College of New York where he earned his undergraduate degree. Rabson then went on to receive his medical degree from the State University of New York Downstate Medical Center in 1950.
Career[edit | edit source]
Rabson began his career in pathology at the National Institutes of Health (NIH) in 1955. He joined the National Cancer Institute in 1955, where he worked in the field of oncology and cancer research. Over the years, he held various positions within the NCI, including director of the Division of Cancer Biology and deputy director of the institute.
Rabson was known for his research on tumor virology and the mechanisms of cancer development. He played a key role in the development of cancer research programs and policies at the NCI.
Contributions to Cancer Research[edit | edit source]
Rabson's work significantly advanced the understanding of cancer biology. He was involved in the study of oncogenes and tumor suppressor genes, which are crucial in the development and progression of cancer. His research contributed to the development of new cancer therapies and diagnostic tools.
Personal Life[edit | edit source]
Alan S. Rabson was married to Ruth L. Kirschstein, a prominent pathologist and the first female director of an NIH institute. They had two children together.
Legacy[edit | edit source]
Rabson's contributions to cancer research and his leadership at the NCI have left a lasting impact on the field of oncology. He was widely respected for his dedication to cancer research and his efforts to improve cancer treatment and prevention.
Death[edit | edit source]
Alan S. Rabson passed away on July 4, 2018, at the age of 92.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
